Trials / Completed
CompletedNCT02161653
Metadoxine as a Therapy for Severe Alcoholic Hepatitis
Impact of Metadoxine in the Oxidative Stress and Early Mortality in Patients With Severe Alcoholic Hepatitis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 135 (actual)
- Sponsor
- Hospital General de Mexico · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether metadoxine is effective for improve survival and reduced oxidative stress in patients with severe alcoholic hepatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prednisone plus Metadoxine | |
| DRUG | Pentoxifylline plus Metadoxine |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2014-06-12
- Last updated
- 2014-11-11
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT02161653. Inclusion in this directory is not an endorsement.